Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • dN/dS ratio (ka/ks) calculation for viral quasispecies

    Hi everyone,

    I am analyzing intrahost viral quasispecies evolution of Hepatitis C virus by Illumina deep-sequencing from lonigtudinal clinical samples. I aim to determine the type of selection (positive or negative) that is acting on different parts of the viral genome. I am wondering how I should calculate the dN/dS ratio for a viral quasispecies.

    Let's say I have a baseline sample A and a sample B from one patient and I would like to analyze the dN/dS ratio for the viral quasispecies between these two samples.

    My question is:

    1) Do I only consider consensus variants within the viral populations for the calculation of the dN/dS ratio?


    2) If not, how do I deal with low frequency variants present within the viral quasispecies when there are multiple SNVs at one position/within a codon?


    3) Is there a tool specifically designed to calculate dN/dS ratios from viral quasispecies populations?


    4) What model should I use to calculate the dN/dS ratio for Hepatitis C virus? Nei Gojobori ... etc.?


    I hope I made myself clear. If something is still unclear, please do not hesitate to ask me.

    Thank you very much in advance!

    Björn

  • #2
    any suggestions?

    Comment

    Latest Articles

    Collapse

    • seqadmin
      Understanding Genetic Influence on Infectious Disease
      by seqadmin




      During the COVID-19 pandemic, scientists observed that while some individuals experienced severe illness when infected with SARS-CoV-2, others were barely affected. These disparities left researchers and clinicians wondering what causes the wide variations in response to viral infections and what role genetics plays.

      Jean-Laurent Casanova, M.D., Ph.D., Professor at Rockefeller University, is a leading expert in this crossover between genetics and infectious...
      09-09-2024, 10:59 AM
    • seqadmin
      Addressing Off-Target Effects in CRISPR Technologies
      by seqadmin






      The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...
      08-27-2024, 04:44 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by seqadmin, Today, 06:25 AM
    0 responses
    13 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, Yesterday, 01:02 PM
    0 responses
    12 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-18-2024, 06:39 AM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Started by seqadmin, 09-11-2024, 02:44 PM
    0 responses
    14 views
    0 likes
    Last Post seqadmin  
    Working...
    X